{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T13:20:27Z","timestamp":1790256027210,"version":"4.1.0"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2014,11,6]],"date-time":"2014-11-06T00:00:00Z","timestamp":1415232000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Nucl Med"],"published-print":{"date-parts":[[2015,2]]},"DOI":"10.1007\/s12149-014-0924-8","type":"journal-article","created":{"date-parts":[[2014,11,5]],"date-time":"2014-11-05T02:53:19Z","timestamp":1415155999000},"page":"164-169","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Investigation of 11C-PiB equivocal PET findings"],"prefix":"10.1007","volume":"29","author":[{"given":"Chisa","family":"Hosokawa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazunari","family":"Ishii","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoko","family":"Hyodo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenta","family":"Sakaguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimio","family":"Usami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenji","family":"Shimamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuzuru","family":"Yamazoe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makoto","family":"Hosono","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazushi","family":"Hanada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masami","family":"Ueda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuma","family":"Saigo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takamichi","family":"Murakami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,11,6]]},"reference":[{"key":"924_CR1","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1002\/ana.20009","volume":"55","author":"WE Klunk","year":"2004","unstructured":"Klunk WE, Engler H, Nordberg A, Wang Y, Blomqvist G, Holt DP, et al. Imaging brain amyloid in Alzheimer\u2019s disease with Pittsburg compound-B. Ann Neurol. 2004;55:306\u201319.","journal-title":"Ann Neurol"},{"key":"924_CR2","doi-asserted-by":"crossref","first-page":"S20","DOI":"10.1016\/j.neurobiolaging.2011.09.006","volume":"32","author":"WE Klunk","year":"2011","unstructured":"Klunk WE. Amyloid imaging as a biomarker for cerebral \u03b2-amyloidosis and risk prediction for Alzheimer dementia. Neurobiol Aging. 2011;32:S20\u201336.","journal-title":"Neurobiol Aging"},{"key":"924_CR3","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1038\/sj.jcbfm.9600146","volume":"25","author":"JC Price","year":"2005","unstructured":"Price JC, Klunk WE, Lopresti BJ, Lu X, Hoge JA, Ziolko S, et al. Kinetic modeling of amyloid binding in humans using PET imaging and Pittsburgh Compound B. J Cereb Blood Flow Metabol. 2005;25:1528\u201347.","journal-title":"J Cereb Blood Flow Metabol"},{"key":"924_CR4","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.neuroimage.2008.04.251","volume":"42","author":"M Yaqub","year":"2008","unstructured":"Yaqub M, Tolboom N, Boellaard R, van Berckel BNM, van Triburg EW, Luurtsema G, et al. Simplified parametric methods for [11C] PIB studies. Neuroimage. 2008;42:76\u201386.","journal-title":"Neuroimage"},{"key":"924_CR5","first-page":"1959","volume":"46","author":"BJ Lopresti","year":"2005","unstructured":"Lopresti BJ, Klunk WE, Mathis CA, Hoge JA, Ziolko SK, Lu X, et al. Simplified quantitation of Pittsburgh compound B amyloid imaging PET studies: a comparable analysis. J Nucl Med. 2005;46:1959\u201372.","journal-title":"J Nucl Med"},{"key":"924_CR6","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.2967\/jnumed.112.113654","volume":"54","author":"BNM Berckel Van","year":"2013","unstructured":"Van Berckel BNM, Ossenkoppele R, Tolboom N, Yaqub M, Foster-Dingley JC, Windhorst AD, et al. Longitudinal amyloid imaging using 11C-PiB: methodological consideration. J Nucl Med. 2013;54:1570\u20136.","journal-title":"J Nucl Med"},{"key":"924_CR7","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1212\/WNL.34.7.939","volume":"34","author":"G McKhann","year":"1984","unstructured":"McKhann G, Drachman D, Foistein M, Katzman R, Price D, Stadian EM. Clinical diagnosis of Alzheimer\u2019s disease-report of the NINCDS-ADRDA work group under the auspices of Department of Health and Human Services Task Force on Alzheimer\u2019s disease. Neurology. 1984;34:939.","journal-title":"Neurology"},{"key":"924_CR8","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1212\/01.wnl.0000187889.17253.b1","volume":"65","author":"IG McKeith","year":"2005","unstructured":"McKeith IG, Dickson DW, Lowe J, Emre M, O\u2019Brien JT, Feldman H, et al. Diagnosis and management of dementia with Lewy bodies. Third report of the DLB consortium. Neurology. 2005;65:1863\u201372.","journal-title":"Neurology"},{"key":"924_CR9","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1001\/archneur.58.12.1985","volume":"58","author":"RC Petersen","year":"2001","unstructured":"Petersen RC, Doody R, Kurz A, Mohs RC, Morris JC, Rabins PV, et al. Current concepts in mild cognitive impairment. Arch Neurol. 2001;58:1985\u201392.","journal-title":"Arch Neurol"},{"key":"924_CR10","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1212\/WNL.51.6.1546","volume":"51","author":"D Neary","year":"1998","unstructured":"Neary D, Snowden JS, Gustafson L, Passant U, Stuss D, Black S, et al. Frontotemporal lobar degeneration\u2014a consensus on clinical diagnostic criteria. Neurology. 1998;51:1546\u201354.","journal-title":"Neurology"},{"key":"924_CR11","doi-asserted-by":"crossref","first-page":"2740","DOI":"10.1021\/jm030026b","volume":"46","author":"CA Mathis","year":"2003","unstructured":"Mathis CA, Wang Y, Holt DP, Huang GF, Debnath ML, Klunk WE. Synthesis and evaluation of 11C-labeled 6-substituted 2-arylbenzothiazoles as amyloid imaging agents. J Med Chem. 2003;46:2740\u201354.","journal-title":"J Med Chem"},{"key":"924_CR12","doi-asserted-by":"crossref","first-page":"198","DOI":"10.2967\/jnumed.108.057984","volume":"50","author":"MT Federo-Tavoletti","year":"2009","unstructured":"Federo-Tavoletti MT, Rowe CC, McLean CA, Leone L, Li QX, Masters CL, et al. Characterization of PiB binding to white matter in Alzheimer disease and other dementias. J Nucl Med. 2009;50:198\u2013204.","journal-title":"J Nucl Med"},{"key":"924_CR13","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1002\/ana.410420114","volume":"42","author":"S Minoshima","year":"1997","unstructured":"Minoshima S, Giordani B, Berent S, Frey KA, Foster NL, Kuhl DE. Metabolic reduction in the posterior cingulate cortex in very early Alzheimer\u2019s disease. Ann Neurol. 1997;42:85\u201394.","journal-title":"Ann Neurol"},{"key":"924_CR14","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1177\/089198870201500405","volume":"15","author":"S Minoshima","year":"2002","unstructured":"Minoshima S, Foster NL, Petrie EC, Albin RL, Frey KA, Kuhl DE. Neuroimaging in dementia with Lewy bodies; metabolism, neurochemistry, and morphology. J Geriatr Psychiatry Neurol. 2002;15:200\u20139.","journal-title":"J Geriatr Psychiatry Neurol"},{"key":"924_CR15","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1093\/brain\/awn016","volume":"131","author":"MD Ikonomovic","year":"2008","unstructured":"Ikonomovic MD, Klunk WE, Abrahamson EE, Mathis CA, Price JC, Tsopelas ND, et al. Post-mortem correlates of in vivo PiB-PET amyloid imaging in a typical case of Alzheimer\u2019s disease. Brain. 2008;131:1630\u201345.","journal-title":"Brain"},{"key":"924_CR16","doi-asserted-by":"crossref","first-page":"547","DOI":"10.2967\/jnumed.106.037762","volume":"48","author":"S Ng","year":"2007","unstructured":"Ng S, Villemagne VL, Berlangieri S, Lee ST, Cherk M, Gong SJ, et al. Visual assessment versus quantitative assessment of 11C-PIB PET and 18F-FDG PET for detection of Alzheimer\u2019s disease. J Nucl Med. 2007;48:547\u201352.","journal-title":"J Nucl Med"},{"key":"924_CR17","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1007\/s00259-010-1382-8","volume":"37","author":"T Suotunen","year":"2010","unstructured":"Suotunen T, Hirvonen J, Immonen-Raiha P, Aalto S, Lisinen I, Arponen E, et al. Visual assessment of [11C]-PIB PET in patients with cognitive impairment. Eur J Nucl Med Mol Imaging. 2010;37:1141\u20137.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"924_CR18","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1016\/j.neuroimage.2011.07.098","volume":"59","author":"EC Mormino","year":"2012","unstructured":"Mormino EC, Brandel MG, Madison CM, Rabinovici GD, Marks S, Baker SL, et al. Not quite PIB-positive, not quite PIB-negative: slight PIB elevations in elderly normal control subjects are biologically relevant. Neuroimage. 2012;59:1152\u201360.","journal-title":"Neuroimage"},{"key":"924_CR19","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.neuroimage.2013.01.015","volume":"71","author":"AD Cohen","year":"2013","unstructured":"Cohen AD, Mowrey W, Weissfeld LA, Aizenstein HJ, McDade E, Mountz JM, et al. Classification of amyloid-positivity in controls: comparison of visual read and quantitative approaches. Neuroimage. 2013;71:207\u201315.","journal-title":"Neuroimage"},{"key":"924_CR20","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/BF00308809","volume":"82","author":"H Braak","year":"1991","unstructured":"Braak H, Braak E. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol. 1991;82:239\u201359.","journal-title":"Acta Neuropathol"},{"key":"924_CR21","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/s00259-011-2045-0","volume":"39","author":"VL Villemagne","year":"2012","unstructured":"Villemagne VL, Klunk WE, Mathis CA, Rowe CC, Brooks DJ, Hyman BT, et al. A\u03b2 Imaging: feasible, pertinent, and vital to progress in Alzheimer\u2019s disease. Eur J Nucl Med Mol Imaging. 2012;39:209\u201319.","journal-title":"Eur J Nucl Med Mol Imaging"}],"container-title":["Annals of Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12149-014-0924-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12149-014-0924-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12149-014-0924-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,2]],"date-time":"2019-06-02T00:41:28Z","timestamp":1559436088000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12149-014-0924-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,11,6]]},"references-count":21,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,2]]}},"alternative-id":["924"],"URL":"https:\/\/doi.org\/10.1007\/s12149-014-0924-8","relation":{},"ISSN":["0914-7187","1864-6433"],"issn-type":[{"value":"0914-7187","type":"print"},{"value":"1864-6433","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,11,6]]}}}